viewCircassia Group PLC

Circassia Pharmaceuticals refutes claims over PPHN product

Circassia acquired exclusive commercialisation rights to LungFit PH in the United States and China

Circassia Pharmaceuticals PLC - Circassia Pharmaceuticals receives termination notice for licencing agreement
One in 500 newborns suffers from the breathing condition

Circassia Pharmaceuticals PLC (LON:CIR) has rejected claims by a licensing partner that it materially breached terms of their agreement over a product for babies with breathing difficulties.

The AIM-listed company has received a notice from BeyondAir, previously known as AIT Therapeutics, to terminate the agreement.

In January, Circassia acquired exclusive commercialisation rights to BeyondAir's LungFit PH product, initially called AirNOvent, in the United States and China.

READ: Circassia completes managerial changes as Johnson becomes executive chairman

LungFit PH is a treatment for persistent pulmonary hypertension (PPHN) in newborns.

PPHN occurs when the pressure in the blood vessels of a baby’s lungs remains high after birth, which can restrict the amount of oxygen flowing around the body.

It is thought to occur in around one in 500 births.

Circassia has refuted the claim of a material breach of the agreement.

“The company will enforce its rights under the agreement and defend its position vigorously,” it added in a statement.

House broker Peel Hunt estimated that "even in a worst-case scenario" removing BeyondAir's contribution from its sales forecasts without any cost offset, "Circassia still turns EBITDA positive in 2020, and maintains a positive cash balance across our forecast period".  

Quick facts: Circassia Group PLC

Price: 24.8 GBX

Market: LSE
Market Cap: £98.54 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...


Guild Esports are 'betting big' after signing top five team in Europe just...

Guild Esports's (LON:GILD) Carleton Curtis talks to Proactive London's Katie Pilbeam about landing a top Swedish team as a new signing - which he says means 'the sky is the limit'. This top-tier squad competing in Valorant, which is a 'stunning game', a 5v5 competitive shooter game launched...

9 hours, 25 minutes ago

2 min read